Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors
Johannes Clausen(Johannes Kepler University of Linz), David Nachbaur(Innsbruck Medical University), Brigitte Kircher(Innsbruck Medical University), A. Mühlbacher(Innsbruck Medical University), Paul Schumacher(Innsbruck Medical University), Christoph Grabmer(Paracelsus Medical University), Günther Gastl(Innsbruck Medical University), Jutta Auberger(Unfallkrankenhaus Salzburg)
Cited by 8
Related Papers
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
|Blood|2014|400
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
|Journal of Clinical Oncology|2011|393
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276